Repeat injections are typically reserved for patients who experience substantial improvement from the initial injection
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of MDX-1100, a Fully Human Anti-CXCL10 Monoclonal Antibody, in Combination With Methotrexate in Patients With Rheumatoid Arthritis
To enable such assessments, the ICE Bioscience team established stable COS7 cell lines overexpressing rat, mouse, dog, and monkey CTR and AMY3R, and developed a fully optimized HTRF-cAMP assay
Consistent with a decrease in oxidant stress in E-Sol5, especially at supercooled temperatures, decreased ROS-mediated conversion of the antioxidant urate into allantoate was observed throughout storage (Supplemental Fig